Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic Dermatitis

Clinical trial NCT07262983 · RECRUITING

Trial details

NCT number: NCT07262983
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hyper IgE Syndrome From STAT3 Mutation Job s Syndrome HIES Lupus Atopic Dermatitis

Start date: 2026-08-26
Primary completion: 2030-05-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.